Samir Gharib
Director of Finance/CFO at SPRUCE BIOSCIENCES, INC.
Net worth: 159 382 $ as of 30/03/2024
Profile
Samir M.
Gharib is currently the Director at Cancer CAREpoint and the President & Chief Financial Officer at Spruce Biosciences, Inc. Previously, he worked as the Finance Director & Controller at Talon Therapeutics, Inc. from 2011 to 2013, the Managing Director at Benchmark Financial Partners LLC from 2017 to 2018, the Vice President-Finance & Administration at Revance Therapeutics, Inc. from 2013 to 2017, and the Chief Financial Officer at Stemedica Cell Technologies, Inc. from 2018 to 2019.
Mr. Gharib obtained his undergraduate degree from Haas School of Business in 2005 and holds an MBA from the same institution.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC.
0.49% | 24/03/2024 | 202,776 ( 0.49% ) | 159 382 $ | 30/03/2024 |
Samir Gharib active positions
| Companies | Position | Start |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director of Finance/CFO | 30/04/2020 |
| Cancer CAREpoint | Director/Board Member | 31/10/2017 |
Former positions of Samir Gharib
| Companies | Position | End |
|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Director of Finance/CFO | 31/08/2019 |
| Benchmark Financial Partners LLC | Corporate Officer/Principal | 30/09/2018 |
| REVANCE THERAPEUTICS, INC. | Chief Administrative Officer | 31/08/2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Comptroller/Controller/Auditor | 31/08/2013 |
Training of Samir Gharib
| Haas School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
| Cancer CAREpoint | |
| Benchmark Financial Partners LLC |
- Stock Market
- Insiders
- Samir Gharib
